Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E in temporal lobe epilepsy: a case-control study.

Amit Kumar1, Manjari Tripathi, Ravindra M Pandey

  • 1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi-110029, India.

Disease Markers
|February 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benign osteoblastoma of maxilla: a case report emphasizing the histopathological differential diagnosis.

Journal of clinical and diagnostic research : JCDR·2014
Same author

Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.

Bioorganic & medicinal chemistry letters·2014
Same author

Coordination mode of pentadentate ligand derivative of 5-amino-1,3,4-thiadiazole-2-thiol with nickel(II) and copper(II) metal ions: synthesis, spectroscopic characterization, molecular modeling and fungicidal study.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2014
Same author

Epigenetic regulation of human cytomegalovirus latency: an update.

Epigenomics·2014
Same author

Differential temporal expression of milk miRNA during the lactation cycle of the marsupial tammar wallaby (Macropus eugenii).

BMC genomics·2014
Same author

Association between Functional Severity and Amputation Type with Rehabilitation Outcomes in Patients with Lower Limb Amputation.

Rehabilitation research and practice·2014
Same journal

Correction to "Estrogen Protects against Renal Ischemia-Reperfusion Injury by Regulating Th17/Treg Cell Immune Balance".

Disease markers·2026
Same journal

RETRACTION: miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.

Disease markers·2026
Same journal

RETRACTION: Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.

Disease markers·2026
Same journal

RETRACTION: Kartogenin Induced Adipose-Derived Stem Cell Exosomes Enhance the Chondrogenic Differentiation Ability of Adipose-Derived Stem Cells.

Disease markers·2026
Same journal

Correction to "KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells".

Disease markers·2026
Same journal

RETRACTION: Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice.

Disease markers·2026
See all related articles

Higher plasma apolipoprotein E (apoE) levels are linked to an increased risk of developing temporal lobe epilepsy (TLE) in Asian Indians. This study highlights apoE

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Epilepsy, particularly temporal lobe epilepsy (TLE), affects millions globally.
  • The role of apolipoprotein E (apoE) in neurological disorders, including epilepsy, is not fully understood.
  • Previous research has not reported on plasma apoE levels in epilepsy patients.

Purpose of the Study:

  • To investigate the association between apolipoprotein E (apoE) genotype, plasma apoE, and lipid levels in Asian Indian patients with temporal lobe epilepsy (TLE).
  • To determine if plasma apoE levels differ between TLE patients and healthy controls.
  • To explore the potential role of apoE in the pathogenesis of TLE.

Main Methods:

  • Case-control study involving 58 TLE patients and 57 controls.

Related Experiment Videos

  • Apolipoprotein E (apoE) gene polymorphism analyzed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
  • Plasma apoE and lipid levels quantified using Enzyme-Linked Immunosorbent Assay (ELISA) and enzymatic kits.

    • Main Results:

    • Apolipoprotein E (apoE) genotype distribution was similar between TLE patients and controls.
    • Significantly higher plasma apoE levels were observed in TLE patients compared to controls (p=0.0001).
    • Elevated plasma apoE levels (>150 mg/L) were associated with a substantially increased odds of developing TLE (4.9 to 20 times higher).

    Conclusions:

    • This study provides the first evidence of elevated plasma apolipoprotein E (apoE) levels in epilepsy patients.
    • The findings suggest that apolipoprotein E may play a significant role in the development or progression of epilepsy.
    • Apolipoprotein E warrants further investigation as a potential biomarker or therapeutic target in TLE.